help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2004-2459
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
90/8/4703    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Guida, T.
Right arrow Articles by Santoro, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Guida, T.
Right arrow Articles by Santoro, M.
Related Collections
Right arrow Endocrine Oncology
Right arrow Thyroid
The Journal of Clinical Endocrinology & Metabolism Vol. 90, No. 8 4703-4709
Copyright © 2005 by The Endocrine Society

Mitogenic Effects of the Up-Regulation of Minichromosome Maintenance Proteins in Anaplastic Thyroid Carcinoma

Teresa Guida, Giuliana Salvatore, Pinuccia Faviana, Riccardo Giannini, Ginesa Garcia-Rostan, Livia Provitera, Fulvio Basolo, Alfredo Fusco, Francesca Carlomagno and Massimo Santoro

Istituto di Endocrinologia ed Oncologia Sperimentale del Consiglio Nazionale delle Ricerche, Dipartimento di Biologia e Patologia Cellulare e Molecolare L. Califano (T.G., G.S., L.P., A.F., F.C., M.S.), Università Federico II, 80131 Naples, Italy; Dipartimento di Oncologia (P.F., R.G., F.B.), Università di Pisa, 56126 Pisa, Italy; and Instituto de Patologia e Imunologia Molecular da Universidade do Porto (G.G.-R.), 4200-465 Porto, Portugal

Address all correspondence and requests for reprints to: Massimo Santoro, Dipartimento di Biologia e Patologia Cellulare e Molecolare L. Califano, Facoltá di Medicina e Chirurgia, via S. Pansini 5, 80131 Naples, Italy. E-mail: masantor{at}unina.it.

Context: Anaplastic thyroid carcinomas (ATC) are among the most aggressive human malignancies and are characterized by high mitotic activity. Minichromosome maintenance proteins (MCM) 2–7 are required to initiate eukaryotic DNA replication, and their overexpression has been associated with dysplasia and malignancy.

Objective: In an attempt to cast light on the mechanisms governing ATC, we evaluated MCM5 and MCM7 expression in human normal, papillary (PTC), and anaplastic thyroid samples, as well as in primary culture cells and transgenic mouse models.

Results: MCM5 and MCM7 expression was high in 65% of ATC and negligible in normal thyroid tissue and papillary thyroid carcinomas. In ATC, high MCM5 and MCM7 expression was paralleled by high levels of MCM2 and MCM6. An analysis of human ATC primary cell cultures and of a transgenic mouse model of ATC confirmed these findings. An increased transcription rate accounted for MCM7 up-regulation, because the activity of the MCM7 promoter was more than 10-fold higher in ATC cells compared with normal thyroid cells. Adoptive overexpression of wild-type p53, but not of its inactive (R248W and R273H) mutants, strongly down-regulated transcription from the MCM7 promoter, suggesting that p53 knock-out contributes to MCM7 up-regulation in ATC. Treatment with small inhibitory duplex RNAs, which decrease MCM7 protein levels, reduced the rate of DNA synthesis in ATC cells.

Conclusion: MCM proteins are overexpressed in ATC and sustain the high proliferative capacity of ATC cells.




This article has been cited by other articles:


Home page
Cancer Res.Home page
G. Salvatore, T. C. Nappi, P. Salerno, Y. Jiang, C. Garbi, C. Ugolini, P. Miccoli, F. Basolo, M. D. Castellone, A. M. Cirafici, et al.
A Cell Proliferation and Chromosomal Instability Signature in Anaplastic Thyroid Carcinoma
Cancer Res., November 1, 2007; 67(21): 10148 - 10158.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
P Hanifi-Moghaddam, B Sijmons, M C Ott, W F J van IJcken, D Nowzari, E C M Kuhne, P van der Spek, H J Kloosterboer, C W Burger, and L J Blok
The hormone replacement therapy drug tibolone acts very similar to medroxyprogesterone acetate in an estrogen-and progesterone-responsive endometrial cancer cell line
J. Mol. Endocrinol., December 1, 2006; 37(3): 405 - 413.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. J. Camp, J. M. Farnham, and L. A. Cannon-Albright
Localization of a Prostate Cancer Predisposition Gene to an 880-kb Region on Chromosome 22q12.3 in Utah High-Risk Pedigrees.
Cancer Res., October 15, 2006; 66(20): 10205 - 10212.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2005 by The Endocrine Society